In cancer cells, this dormant pathway is reactivated, increasing circulating levels of PTHrP [15], which leads to the elevation of the extracellular calcium concentration in a tumor-burden- and aggressiveness-dependent manner [16,17]. Here, PTHLH is linked to cancer.